参考文献/References:
[1].McDonagh TA,Metra M,Adamo M,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. Eur Heart J,2021,42(36):3599-3726.
[2].[2] 马丽媛,王增武,樊静,等. 《中国心血管健康与疾病报告2021》概要[J]. 中国介入心脏病学杂志,2022,30(7):481-496.
[3].[3] Simental-Mendia LE,Rodriguez-Moran M,Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects[J]. Metab Syndr Relat Disord,2008,6(4):299-304.
[4].[4] Almeda-Valdés P,Bello-Chavolla OY,Caballeros-Barragán CR,et al.?ndices para la evaluación de la resistencia a la insulina en individuos mexicanos sin diabetes[J]. Gac Med Mex,2018,154(Supp 2):s50-s55.
[5].[5] Mazidi M,Kengne AP,Katsiki N,et al. Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance[J]. J Diabetes Complications,2018,32(3):26 6-270.
[6].[6] Dikaiakou E,Vlachopapadopoulou EA,Paschou SA,et al. Τriglycerides-glucose (TyG) index is a sensitive marker of insulin resistance in Greek children and adolescents[J]. Endocrine, 2020 ,70(1):58-64.
[7].[7] Huang R,Lin Y,Ye X,et al. Triglyceride-glucose index in the development of heart failure and left ventricular dysfunction:analysis of the ARIC study[J]. Eur J Prev Cardiol,2022,29(11):1531-1541.
[8].[8] Li X,Chan J,Guan B,et al. Triglyceride-glucose index and the risk of heart failure:evidence from two large cohorts and a mendelian randomization analysis[J]. Cardiovasc Diabetol, 2022 ,21(1):229.
[9].[9] Huang H,Li Q,Liu J,et al. Association between triglyceride glucose index and worsening heart failure in significant secondary mitral regurgitation following percutaneous coronary intervention[J]. Cardiovasc Diabetol,2022,21(1):260.
[10].[10] Han S,Wang C,Tong F,et al. Triglyceride glucose index and its combination with the get with the Guidelines-Heart Failure score in predicting the prognosis in patients with heart failure[J]. Front Nutr,2022,9950338.
[11].[11] Jia G,Whaley-Connell A,Sowers JR. Diabetic cardiomyopathy:a hyperglycaemia- and insulin-resistance-induced heart disease[J]. Diabetologia,2018,61(1):21-28.
[12].[12] Henstridge DC,Whitham M,Febbraio MA. Chaperoning to the metabolic party:the emerging therapeutic role of heat-shock proteins in obesity and type 2 diabetes[J]. Mol Metab,2014,3(8):781-793.
[13].[13] Jia G,Habibi J,DeMarco VG,et al. Endothelial mineralocorticoid receptor deletion prevents diet-induced cardiac diastolic dysfunction in females[J]. Hypertension,2015,66(6):1159-1167.
[14].[14] Zhao J,Randive R,Stewart JA. Molecular mechanisms of AGE/RAGE-mediated fibrosis in the diabetic heart[J]. World J Diabetes,2014,5(6):860-867.
[15].[15] Jia G,DeMarco VG,Sowers JR. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy[J]. Nat Rev Endocrinol,2016,12(3):144-153.
[16].[16] Makino A,Dai A,Han Y,et al. O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice[J]. Am J Physiol Cell Physiol,2015,309(9):c593-599.
[17].[17] Huang YC,Huang JC,Lin CI,et al. Comparison of innovative and traditional cardiometabolic indices in estimating atherosclerotic cardiovascular disease risk in adults[J]. Diagnostics (Basel),2021,11(4):603.
[18].[18] Barzegar N,Tohidi M,Hasheminia M,et al. The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up:Tehran Lipid and Glucose Study[J]. Cardiovasc Diabetol,2020,19(1):155.
[19].[19] Won KB,Lee BK,Park HB,et al. Quantitative assessment of coronary plaque volume change related to triglyceride glucose index:The Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging (PARADIGM) registry[J]. Cardiovasc Diabetol,2020,19(1):113.
[20].[20] Thai PV,Tien HA,Van Minh H,et al. Triglyceride glucose index for the detection of asymptomatic coronary artery stenosis in patients with type 2 diabetes[J]. Cardiovasc Diabetol,2020,19(1):137.
[21].[21] Reardon CA,Lingaraju A,Schoenfelt KQ,et al. Obesity and Insulin Resistance Promote Atherosclerosis through an IFNγ-Regulated Macrophage Protein Network[J]. Cell reports,2018,23(10):3021-3030.
[22].[22] Hari Kumar KVS. The good,the bad,and the ugly facets of insulin resistance[J]. Med J Armed Forces India,2020,76(1):4-7.
[23].[23] Zhu B,Wang J,Chen K,et al. A high triglyceride glucose index is more closely associated with hypertension than lipid or glycemic parameters in elderly individuals:a cross-sectional survey from the Reaction Study[J]. Cardiovasc Diabetol,2020,19(1):112.
[24].[24] Simental-Mendía LE,Hernández-Ronquillo G,Gamboa-Gómez CI,et al. The triglycerides and glucose index is associated with elevated blood pressure in apparently healthy children and adolescents[J]. Eur J Pediatr,2019,178(7):1069-1074.
[25].[25] Cai Q,Xing CY,Zhu J,et al. Associations between triglyceride-glucose index and different hypertension subtypes:a population-based study in China[J]. Front Cardiovasc Med,2022,9 901180.
[26].[26] Bala C,Gheorghe-Fronea O,Pop D,et al. The association between six surrogate insulin resistance indexes and hypertension:a Population-Based Study[J]. Metab Syndr Relat Disord,2019,17(6):328-333.
[27].[27] Sánchez-??igo L,Navarro-González D,Pastrana-Delgado J,et al. Association of triglycerides and new lipid markers with the incidence of hypertension in a Spanish cohort[J]. J Hypertension,2016,34(7):1257-1265.
[28].[28] Morales-Gurrola G,Simental-Mendía LE,Castellanos-Juárez FX,et al. The triglycerides and glucose index is associated with cardiovascular risk factors in metabolically obese normal-weight subjects[J]. J Endocrinol Invest,2020,43(7):995-1000.
[29].[29] Soleimani M. Insulin resistance and hypertension:new insights[J]. Kidney Int,2015,87(3):497-499.
[30].[30] da Silva AA,do Carmo JM,Li X,et al. Role of Hyperinsulinemia and insulin resistance in hypertension:metabolic syndrome revisited[J]. Can J Cardiol,2020,36(5):671-682.
[31].[31] Muniyappa R,Chen H,Montagnani M,et al. Endothelial dysfunction due to selective insulin resistance in vascular endothelium:insights from mechanistic modeling[J]. Am J Physiol Endocrinol Metab,2020,319(3):e629-e646.
[32].[32] Alpert MA,Omran J,Bostick BP. Effects of obesity on cardiovascular hemodynamics,cardiac morphology,and ventricular function[J]. Curr Obes Rep,2016,5(4):424-434.
[33].[33] Zheng Y,Ley SH,Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications[J]. Nat Rev Endocrinol,2018,14(2):88-98.
[34].[34] Li X,Sun M,Yang Y,et al. Predictive effect of triglyceride glucose-related parameters,obesity indices,and lipid ratios for diabetes in a Chinese population:a Prospective Cohort Study[J]. Front Endocrinol (Lausanne),2022,13:862919.
[35].[35] Park B,Lee HS,Lee YJ. Triglyceride glucose (TyG) index as a predictor of incident type 2 diabetes among nonobese adults:a 12-year longitudinal study of the Korean Genome and Epidemiology Study cohort[J]. Transl Res,2021,228:42-51.
[36].[36] Pan L,Gao Y,Han J,et al. Comparison of longitudinal changes in four surrogate insulin resistance indexes for incident T2DM in middle-aged and elderly Chinese[J]. Front Public Health,2022,10:1046223.
[37].[37] Chen CL,Liu L,Lo K,et al. Association Between Triglyceride Glucose Index and Risk of New-Onset Diabetes Among Chinese Adults:Findings From the China Health and Retirement Longitudinal Study[J]. Front Cardiovasc Med,2020,7:610322.
[38].[38] Alejandro EU,Gregg B,Blandino-Rosano M,et al. Natural history of β-cell adaptation and failure in type 2 diabetes[J]. Mol Aspects Med,2015,42:19-41.
相似文献/References:
[1]丁娟,刘地川.心力衰竭与线粒体功能障碍的研究进展[J].心血管病学进展,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
DING Juan,LIU Dichuan.Research Progress of Heart Failure and Mitochondrial Dysfunction[J].Advances in Cardiovascular Diseases,2016,(8):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
[2]罗秀林,综述,张烁,等.肾动脉去交感神经术治疗心力衰竭——希望还是炒作[J].心血管病学进展,2016,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
LUO Xiulin,ZHANG Shuo.Renal Sympathetic Denervation for Heart Failure—Hopes or Hypes[J].Advances in Cardiovascular Diseases,2016,(8):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
[3]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(8):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[4]李慧,综述,齐国先,等.老年射血分数保留的心功能不全研究进展[J].心血管病学进展,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
LI Hui,QI Guoxian.Research Progress of Heart Failure with Preserved Ejection Fraction in Elderly People[J].Advances in Cardiovascular Diseases,2016,(8):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
[5]亢玉,综述,张庆,等.二尖瓣瓣叶在功能性二尖瓣反流发生机制中的角色[J].心血管病学进展,2016,(4):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
KANG Yu,ZHANG Qing.Role of Mitral Leaflets in Pathogenesis of Functional Mitral Regurgitation[J].Advances in Cardiovascular Diseases,2016,(8):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
[6]史秀莉,张庆,喻鹏铭.心力衰竭患者运动训练方式及其疗效的研究进展[J].心血管病学进展,2015,(5):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
SHI Xiuli,ZHANG Qing,YU Pengming.Exercise Training Modalities and Their Treatment Effects on
Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2015,(8):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
[7]熊卓超,陈康玉,严激.无创血流动力学评价在心力衰竭中的应用进展[J].心血管病学进展,2019,(6):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
XIONG Zhuochao,CHEN Kangyu,YAN Ji.Application Progress of Noninvasive Hemodynamic Evaluation in Heart Failure[J].Advances in Cardiovascular Diseases,2019,(8):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
[8]高薇 陈伟.铁过载性心肌病[J].心血管病学进展,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
GAO WeiCHEN Wei.Iron Overload Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(8):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
[9]何燕 刘育.C型利钠肽与心力衰竭[J].心血管病学进展,2019,(5):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
HE Yan,LIU Yu.C-type Natriuretic Peptide and Heart Failure[J].Advances in Cardiovascular Diseases,2019,(8):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
[10]吴彤 高东来.心房颤动合并心力衰竭的射频消融治疗[J].心血管病学进展,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
WU TongGAO Donglai.Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2019,(8):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]